These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12798587)

  • 1. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.
    Lemos PA; Lee CH; Degertekin M; Saia F; Tanabe K; Arampatzis CA; Hoye A; van Duuren M; Sianos G; Smits PC; de Feyter P; van der Giessen WJ; van Domburg RT; Serruys PW
    J Am Coll Cardiol; 2003 Jun; 41(11):2093-9. PubMed ID: 12798587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.
    Lemos PA; Serruys PW; van Domburg RT; Saia F; Arampatzis CA; Hoye A; Degertekin M; Tanabe K; Daemen J; Liu TK; McFadden E; Sianos G; Hofma SH; Smits PC; van der Giessen WJ; de Feyter PJ
    Circulation; 2004 Jan; 109(2):190-5. PubMed ID: 14691037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
    Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study.
    Simsek C; Räber L; Magro M; Boersma E; Onuma Y; Stefanini GG; Zanchin T; Kalesan B; Wenaweser P; Jüni P; van Geuns RJ; van Domburg RT; Windecker S; Serruys PW
    Int J Cardiol; 2013 Dec; 170(1):36-42. PubMed ID: 24196314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P
    J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors of cardiac events after implantation of sirolimus-eluting stents for treatment of in-stent restenosis.
    Le Feuvre C; Montalescot G; Rosey G; Collet JP; Beygui F; Choussat R; Gelft G; Monségu J; Ohanessian A; Spaulding C; Drobinski G; Metzger JP
    Int J Cardiol; 2006 May; 109(2):207-12. PubMed ID: 15993962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: a comparison between the RESEARCH and T-SEARCH registries.
    Rodriguez-Granillo GA; Valgimigli M; Garcia-Garcia HM; Ong AT; Aoki J; van Mieghem CA; Tsuchida K; Sianos G; McFadden E; van der Giessen WJ; van Domburg R; de Feyter P; Serruys PW
    J Invasive Cardiol; 2005 Aug; 17(8):409-12. PubMed ID: 16079445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation.
    Ong AT; Hoye A; Aoki J; van Mieghem CA; Rodriguez Granillo GA; Sonnenschein K; Regar E; McFadden EP; Sianos G; van der Giessen WJ; de Jaegere PP; de Feyter P; van Domburg RT; Serruys PW
    J Am Coll Cardiol; 2005 Mar; 45(6):947-53. PubMed ID: 15766834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results.
    Orlic D; Bonizzoni E; Stankovic G; Airoldi F; Chieffo A; Corvaja N; Sangiorgi G; Ferraro M; Briguori C; Montorfano M; Carlino M; Colombo A
    J Am Coll Cardiol; 2004 Apr; 43(7):1154-60. PubMed ID: 15063422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.
    Ong AT; van Domburg RT; Aoki J; Sonnenschein K; Lemos PA; Serruys PW
    J Am Coll Cardiol; 2006 Apr; 47(7):1356-60. PubMed ID: 16580521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis: one-year clinical outcomes of 99 consecutive patients--the Rotterdam experience.
    Arampatzis CA; Hoye A; Lemos PA; Saia F; Tanabe K; Degertekin M; Sianos G; Smits PC; van der Giessen WJ; McFadden E; van Domburg R; de Feyter P; Serruys PW
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):57-60. PubMed ID: 15343568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical follow-up after sirolimus-eluting stent versus bare metal stent implantation in patients with acute coronary syndrome.
    Ogita M; Nakamura T; Fujiwara N; Sakakura K; Funayama H; Sugawara Y; Kubo N; Ako J; Momomura S
    J Interv Cardiol; 2009 Jun; 22(3):216-21. PubMed ID: 19490360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and angiographic outcomes after overdilatation of undersized sirolimus-eluting stents with largely oversized balloons: an observational study.
    Saia F; Lemos PA; Arampatzis CA; Hoye A; McFadden E; Sianos G; Smits PC; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):455-60. PubMed ID: 15065137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry.
    Shen ZJ; García-García HM; Garg S; Onuma Y; Schenkeveld L; van Domburg RT; Serruys PW;
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):979-86. PubMed ID: 19753636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of the sirolimus-eluting stent in the treatment of patients with a prior history of coronary artery bypass graft surgery.
    Hoye A; Lemos PA; Arampatzis CA; Saia F; Tanabe K; Degertekin M; Hofma S; McFadden E; Sianos G; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Serruys PW
    Coron Artery Dis; 2004 May; 15(3):171-5. PubMed ID: 15096998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry.
    Ong AT; Serruys PW; Aoki J; Hoye A; van Mieghem CA; Rodriguez-Granillo GA; Valgimigli M; Sonnenschein K; Regar E; van der Ent M; de Jaegere PP; McFadden EP; Sianos G; van der Giessen WJ; de Feyter PJ; van Domburg RT
    J Am Coll Cardiol; 2005 Apr; 45(7):1135-41. PubMed ID: 15808774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus-eluting stents in real-world patients with ST-segment elevation acute myocardial infarction.
    Zhang F; Ge J; Qian J; Fan B; Wang Q; Ge L; Liu X
    Int Heart J; 2007 May; 48(3):303-11. PubMed ID: 17592195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of three or more versus a single sirolimus-eluting stent on outcomes in patients who undergo percutaneous coronary intervention.
    Chu WW; Kuchulakanti PK; Rha SW; GebreEyesus A; Aggrey G; Torguson R; Wang B; Xue Z; Clavijo LC; Suddath WO; Pichard AD; Satler LF; Kent KM; Waksman R
    Am J Cardiol; 2006 Mar; 97(5):606-10. PubMed ID: 16490422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective native coronary artery stenosis treated with sirolimus-eluting stent (ONASSIS) registry--acute results and mid-term outcomes: a single-center experience.
    Voudris V; Alexopoulos E; Karyofillis P; Malakos J; Manginas A; Spargias C; Pavlides G; Patsilinakos S; Anyfantakis A; Cokkinos DV
    J Invasive Cardiol; 2005 Aug; 17(8):401-5. PubMed ID: 16079443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.